about
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.Targeting the duality of cancer.Revisiting the IGF-1R as a breast cancer target.Fishing for cures: The alLURE of using zebrafish to develop precision oncology therapies.Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated light.Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule.Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy.Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma.Inhibiting breast cancer by targeting the thromboxane A2 pathway.The Hormel Institute International Cancer Research Conference—2017 meeting report.Immune cell profiling in cancer: molecular approaches to cell-specific identification.Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution.Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway.SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response.Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival.Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma.Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems.Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor.ALKG1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor.EBV based cancer prevention and therapy in nasopharyngeal carcinoma.Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2.Towards personalized tumor markers.Plasma fatty acids and risk of colon and rectal cancers in the Singapore Chinese Health Study.Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling.Precision medicine: the foundation of future cancer therapeutics.Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression.Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.The therapeutic potential of resveratrol: a review of clinical trials.Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event.A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.Network-based machine learning and graph theory algorithms for precision oncology.The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients.Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.The potential of liquid biopsies for the early detection of cancer.Circulating tumor cells: quintessential precision oncology presenting challenges for biology.Role of nonresolving inflammation in hepatocellular carcinoma development and progression.
P1433
Q51825149-3E9C7179-1F8C-4B4C-8BC0-1C9E96BA18E8Q52539731-8259479B-7F2E-4885-A487-931FFB7D1994Q52686152-2E0F5932-B812-4A0B-8308-2CA45284C190Q52703978-4F105425-6D8D-4E46-96A2-E94683E49A70Q52741776-FC18ED2A-0F3E-492C-8E46-685694D8CBD8Q52772691-90131828-1226-408B-8F42-129CE74605F1Q52808412-65D64379-330F-4484-870A-E352AF641420Q53499541-DDD4AC37-CB24-4F8D-B33A-758537D586A7Q53601791-017CEC7C-E016-4D4A-96DE-B4F963131F24Q53718494-A0620A44-4B7E-4901-A8F1-999D3B8FEA61Q54938762-FDC91FD6-FBDC-4908-86B2-6148125CA26EQ54943781-02943CCE-42C6-4289-8A56-EFABEC943154Q54947687-76E4F7DE-8DF2-4601-8B5F-195709A5D7CDQ54957080-3AD8921F-E9D4-402D-854D-60E372ECBDDAQ54976921-46E48FBF-7A7D-4FF5-9504-3A61BEAA6631Q54976922-7D1FC9B9-65E8-4D25-A5E6-D5CF36DBFB77Q54976923-EC4E9C56-3EB9-4B90-8CB3-A756F7A3077AQ54976924-0F5639F0-58FA-4EA3-8640-6DE76C47C2D9Q54994571-A7042931-ECD0-4766-9DE0-A173E2B88880Q54995893-EACEF57F-640D-4A5D-8C20-90E1E4F9A73EQ55001604-9F080200-6CF8-467E-B44B-695864A043D8Q55003763-5DB5642C-0703-47BB-AC2A-6A3CD8830D96Q55003764-B3216E5B-AFBD-44AF-891F-4BEC2E432D8BQ55003883-EFC734B6-87D7-4473-86D3-F26C45C6275FQ55004046-26929E26-37F6-4ADA-A0B7-D0311A94E1CBQ55011612-9AAE4DE1-D04D-48CC-AC43-5EECFA6A7BF3Q55014420-A96EE802-164D-4C4D-AF09-39AE164ECCE9Q55030833-7255EF62-F644-47DE-960F-3EF00908A715Q55040682-55A46115-8387-4FE5-A8D2-317AC9767700Q55076084-150E539B-51D0-45D0-8432-7F3964411A42Q55098105-F964B38F-C810-4118-81E1-FDD5D646F660Q55151370-CBF4292E-F5D5-4103-9014-D6AE4993B303Q55178627-06D69A97-D2FE-4707-B7CA-670F78536568Q55259943-D4993080-9B12-4F9B-9AC9-44750E717914Q55260352-921E36D4-519C-4822-BCD8-0C2F3555CB95Q55262527-29C11E8D-D2CE-4359-BCCC-7BA14E532C0CQ55262612-6AC28F45-2455-4A4B-A903-D95C6D4F40D3Q55269325-622C87D3-7AB3-4957-A3A2-16D902AE67C7Q55272709-B1F4FE62-A99E-4E32-A04C-809002C29029Q55288642-C5AC92A3-8ED1-4F97-BC0F-34B6D5FEDD3F
P1433
description
Academic journal published by ...... cluding cancer and carcinogens
@en
academisch tijdschrift
@nl
name
npj Precision Oncology
@en
npj Precision Oncology
@nl
type
label
npj Precision Oncology
@en
npj Precision Oncology
@nl
prefLabel
npj Precision Oncology
@en
npj Precision Oncology
@nl